Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Microspheres in Low Risk CAP
NCT00140023Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of azithromycin microspheres in community acquired pneumonia (CAP), sponsored by Pfizer. Primary endpoint: Clinical Efficacy at Test of Cure. Started Sep 2005; status: completed.
02
Drugs
azithromycin microspheres
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00140023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140023.